UnitedHealth Group Inc. (NYSE:UNH) updated its FY16 earnings guidance on Monday. The company provided EPS guidance of ~$8.00 for the period, compared to the Thomson Reuters consensus EPS estimate of $8.01. The company issued revenue guidance of exceed $184 billion, compared to the consensus revenue estimate of $184.24 billion.UnitedHealth Group also updated its FY17 guidance to $9.30-9.60 EPS.
A number of analysts recently issued reports on the stock. Leerink Swann reissued a buy rating on shares of UnitedHealth Group in a research report on Wednesday, November 23rd. Mizuho downgraded shares of UnitedHealth Group from a buy rating to a neutral rating in a research report on Wednesday, November 9th. Credit Suisse Group AG reissued an outperform rating and set a $160.00 target price (up previously from $155.00) on shares of UnitedHealth Group in a research report on Friday, October 21st. Vetr downgraded shares of UnitedHealth Group from a buy rating to a hold rating and set a $144.66 target price for the company. in a research report on Tuesday, October 18th. Finally, Jefferies Group reissued a buy rating and set a $163.00 target price on shares of UnitedHealth Group in a research report on Sunday, October 16th. Two investment analysts have rated the stock with a hold rating and twenty-two have issued a buy rating to the stock. UnitedHealth Group currently has an average rating of Buy and a consensus price target of $158.03.
UnitedHealth Group Inc. (NYSE:UNH) traded down 0.46% on Monday, reaching $152.11. The company had a trading volume of 5,022,994 shares. The company has a market capitalization of $144.61 billion, a price-to-earnings ratio of 25.31 and a beta of 0.63. UnitedHealth Group Inc. has a 12 month low of $107.51 and a 12 month high of $154.50. The company’s 50 day moving average price is $143.37 and its 200-day moving average price is $139.61.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 18th. The healthcare conglomerate reported $2.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.08 by $0.09. The business had revenue of $46.30 billion for the quarter, compared to analysts’ expectations of $46.09 billion. UnitedHealth Group had a return on equity of 19.92% and a net margin of 3.62%. UnitedHealth Group’s quarterly revenue was up 11.6% on a year-over-year basis. During the same period in the previous year, the business posted $1.77 earnings per share. On average, equities analysts predict that UnitedHealth Group Inc. will post $8.01 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 13th. Stockholders of record on Friday, December 2nd will be given a dividend of $0.625 per share. This represents a $2.50 dividend on an annualized basis and a dividend yield of 1.64%. The ex-dividend date of this dividend is Wednesday, November 30th. UnitedHealth Group’s dividend payout ratio is presently 36.93%.
In related news, Director Richard T. Burke sold 40,000 shares of the business’s stock in a transaction on Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total value of $5,412,400.00. Following the sale, the director now owns 2,003,550 shares of the company’s stock, valued at approximately $271,100,350.50. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP D Ellen Wilson sold 14,365 shares of the business’s stock in a transaction on Friday, October 21st. The shares were sold at an average price of $144.18, for a total value of $2,071,145.70. Following the completion of the sale, the executive vice president now directly owns 66,635 shares in the company, valued at approximately $9,607,434.30. The disclosure for this sale can be found here. 1.65% of the stock is owned by corporate insiders.
A number of hedge funds have recently made changes to their positions in UNH. Van Hulzen Asset Management LLC bought a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $104,000. Eubel Brady & Suttman Asset Management Inc. bought a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $209,000. Bellwether Investment Group LLC bought a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $220,000. Ancora Advisors LLC bought a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $238,000. Finally, MCF Advisors LLC raised its stake in shares of UnitedHealth Group by 79.6% in the second quarter. MCF Advisors LLC now owns 1,721 shares of the healthcare conglomerate’s stock valued at $243,000 after buying an additional 763 shares in the last quarter. 84.92% of the stock is currently owned by institutional investors and hedge funds.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.